322 related articles for article (PubMed ID: 33472404)
1. Identification of Celastrol as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A).
Kurosawa R; Satoh K; Nakata T; Shindo T; Kikuchi N; Satoh T; Siddique MAH; Omura J; Sunamura S; Nogi M; Takeuchi Y; Miyata S; Shimokawa H
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1205-1217. PubMed ID: 33472404
[TBL] [Abstract][Full Text] [Related]
2. Basigin mediates pulmonary hypertension by promoting inflammation and vascular smooth muscle cell proliferation.
Satoh K; Satoh T; Kikuchi N; Omura J; Kurosawa R; Suzuki K; Sugimura K; Aoki T; Nochioka K; Tatebe S; Miyamichi-Yamamoto S; Miura M; Shimizu T; Ikeda S; Yaoita N; Fukumoto Y; Minami T; Miyata S; Nakamura K; Ito H; Kadomatsu K; Shimokawa H
Circ Res; 2014 Sep; 115(8):738-50. PubMed ID: 25149188
[TBL] [Abstract][Full Text] [Related]
3. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.
Inagaki T; Pearson JT; Tsuchimochi H; Schwenke DO; Saito S; Higuchi T; Masaki T; Umetani K; Shirai M; Nakaoka Y
Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1021-H1036. PubMed ID: 33481696
[TBL] [Abstract][Full Text] [Related]
5. Development of Novel Therapies for Cardiovascular Diseases by Clinical Application of Basic Research.
Satoh K
Circ J; 2017 Oct; 81(11):1557-1563. PubMed ID: 28993547
[TBL] [Abstract][Full Text] [Related]
6. Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and postcapillary pulmonary hypertension in mice.
Sunamura S; Satoh K; Kurosawa R; Ohtsuki T; Kikuchi N; Elias-Al-Mamun M; Shimizu T; Ikeda S; Suzuki K; Satoh T; Omura J; Nogi M; Numano K; Siddique MAH; Miyata S; Miura M; Shimokawa H
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7129-E7138. PubMed ID: 29987023
[TBL] [Abstract][Full Text] [Related]
7. Identification of Emetine as a Therapeutic Agent for Pulmonary Arterial Hypertension: Novel Effects of an Old Drug.
Siddique MAH; Satoh K; Kurosawa R; Kikuchi N; Elias-Al-Mamun M; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Ueda H; Tokuyama H; Shimokawa H
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2367-2385. PubMed ID: 31533472
[TBL] [Abstract][Full Text] [Related]
8. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation.
Xue C; Sowden M; Berk BC
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1138-1146. PubMed ID: 28450293
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension.
Shults NV; Kanovka SS; Ten Eyck JE; Rybka V; Suzuki YJ
J Am Heart Assoc; 2019 Mar; 8(5):e011227. PubMed ID: 30807241
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.
Philip JL; Murphy TM; Schreier DA; Stevens S; Tabima DM; Albrecht M; Frump AL; Hacker TA; Lahm T; Chesler NC
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1167-H1177. PubMed ID: 30767670
[TBL] [Abstract][Full Text] [Related]
15. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the cyclophilin A-CD147 interaction attenuates right ventricular injury and dysfunction after acute pulmonary embolism in rats.
Lu G; Jia Z; Zu Q; Zhang J; Zhao L; Shi H
J Biol Chem; 2018 Aug; 293(31):12199-12208. PubMed ID: 29914983
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
[TBL] [Abstract][Full Text] [Related]
19. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
[TBL] [Abstract][Full Text] [Related]
20. Distinct right ventricle remodeling in response to pressure overload in the rat.
Mendes-Ferreira P; Santos-Ribeiro D; Adão R; Maia-Rocha C; Mendes-Ferreira M; Sousa-Mendes C; Leite-Moreira AF; Brás-Silva C
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H85-95. PubMed ID: 27199115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
